Research Nester released a report titled “Structural Heart Devices Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global structural heart devices market in terms of market segmentation by product, by procedure, by indication and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The devices used to treat structural heart diseases caused due to problems with the heart valves or tissues are structural heart devices. They are used for the treatment of congenital heart defects along with other similar diseases. The market for structural heart devices is anticipated to grow at a CAGR of about 9.5% over the forecast period, i.e., 2019-2027. The market is segmented by product, by procedure, by indication and by region. On the basis of product, the market is segmented into heart valves, occluders, annuloplasty rings, accessories and others, out of which, the heart valves segment is predicted to hold the largest share in the structural heart devices market. On the other hand, the procedure segment is bifurcated into repair and replacement, out of which, the replacement procedure segment is estimated to witness the highest growth on account of rising demand for trans-catheter replacement procedures.

The market in North America is anticipated to hold the leading share in structural heart devices market on account of growing number of structural heart disease related surgeries taking place in the region. Moreover, the various advancements in medical technology and rising expenditure on healthcare by the people in this region are estimated to contribute towards the market growth as well. On the other hand, the market in Asia Pacific region is predicted to grow at the highest rate over the forecast period on account of the large population and unhealthy lifestyle in Asian countries including China and India.

Demand for Structural Heart Devices to Grow as Developments in Medical Technology Rise

The rising developments resulting in the production of new and innovative devices for the treatment of structural heart diseases such as annuloplasty rings and occluders is a significant factor anticipated to contribute towards the market growth. However, the treatment for structural heart diseases requires surgery which can be a highly costly procedure and is estimated to hamper the market growth.

This report also provides the existing competitive scenario of some of the key players of the global structural heart devices market which includes company profiling of Abbott (NYSE: ABT), Boston Scientific Corporation (NYSE: BSX), Edwards Lifesciences (NYSE: EW), Medtronic (NYSE: MDT), Corvia Medical, Inc., Comed B.V., JenaValve Technology, Inc., LivaNova PLC (NASDAQ: LIVN), XELTIS and CryoLife, Inc. (NYSE: CRY). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global structural heart devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.